Whitepaper | 10/1/2017

Looking Forward: Catalysts for Change in CAR-T

Zach Donnell, Divya Harjani, Amanda Sani, Ned Wydysh, and Vivek Mittal
CAR-T cell therapy is currently one of the most exciting areas of clinical research. To create these living therapies, human T cells are genetically modified to express a CAR (chimeric antigen receptor) that has been programmed to target specific antigens found on the surface of cancer cells.
Read here.